Ron Cohen

2022

In 2022, Ron Cohen earned a total compensation of $984.2K as President and Chief Executive Officer at Acorda Therapeutics, a 40% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$350,000
Salary$625,000
Other$9,150
Total$984,150

Cohen received $625K in salary, accounting for 64% of the total pay in 2022.

Cohen also received $350K in non-equity incentive plan and $9.2K in other compensation.

Rankings

In 2022, Ron Cohen's compensation ranked 3,071st out of 5,760 executives tracked by ExecPay. In other words, Cohen earned more than 46.7% of executives.

ClassificationRankingPercentile
All
3,071
out of 5,760
47th
Division
Manufacturing
1,727
out of 3,136
45th
Major group
Chemicals And Allied Products
811
out of 1,422
43rd
Industry group
Drugs
757
out of 1,323
43rd
Industry
Biological Products, Except Diagnostic Substances
182
out of 291
38th

Pay ratio

Ron Cohen's Pay$984,150
Median Employee's Pay$218,380
Pay Ratio

5

to 1

In 2022, the annual total compensation of Ron Cohen was $984,150.

The annual total compensation of the median employee at Acorda Therapeutics was $218,380.

The ratio of Ron Cohen's pay to the pay of median employee was therefore 5 to one.

Source: SEC filing on April 27, 2023.

Cohen's colleagues

We found three more compensation records of executives who worked with Ron Cohen at Acorda Therapeutics in 2022.

2022

Kerry Clem

Acorda Therapeutics

Chief Commercial Officer

2022

Lauren Sabella

Acorda Therapeutics

Chief Operating Officer

2022

Michael Gesser

Acorda Therapeutics

Chief Finance Officer and Treasurer

News

You may also like